TP53 and cancer: These results suggest that restoration of ‘WT-like’ p53 functions to mutant p53 by an ITC, synthetic or naturally occurring dietary-related, could abolish mutant p53 GOF activity to induce upregulation of MDR1 expression in cancer cells.